PRVB has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
PRVB has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Provention Bio has the Momentum Rank of 0.
For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.
Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.
For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Thank you for viewing the detailed overview of Provention Bio's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.
Sessa Capital (master), L.p. | 10 percent owner | 888 SEVENTH AVENUE, 30TH FLOOR, NEW YORK NY 10019 |
Ashleigh Palmer | director, 10 percent owner, officer: President and CEO | PROVENTION BIO, INC., 110 OLD DRIFTWAY LANE, LEBANON NJ 08833 |
Francisco Leon | director, 10 percent owner, officer: Chief Scientific Officer | C/O PROVENTION BIO, INC., 110 OLD DRIFTWAY LANE, LEBANON NJ 08833 |
Jason Hoitt | officer: Chief Commercial Officer | C/O DOVA PHARMACEUTICALS, INC., 240 LEIGH FARM ROAD, SUITE 245, DURHAM NC 27707 |
Justin Vogel | officer: Chief Accounting Officer | C/O PROVENTION BIO, INC., 55 BROAD STREET, RED BANK NJ 07701 |
Rita Jain | director | C/O AKEBIA THERAPEUTICS, INC., 245 FIRST STREET, SUITE 1100, CAMBRIDGE MA 02142 |
Sarah O'brien | officer: Chief People Officer | C/O PROVENTION BIO, INC., 55 BROAD STREET, RED BANK NJ 07701 |
Sessa Capital Im, L.p. | 10 percent owner | 888 SEVENTH AVENUE, 30TH FLOOR, NEW YORK NY 10019 |
John Petry | 10 percent owner | 888 SEVENTH AVENUE, 30TH FLOOR, NEW YORK NY 10019 |
Sessa Capital Gp, Llc | 10 percent owner | 888 SEVENTH AVENUE, 30TH FLOOR, NEW YORK NY 10019 |
Sessa Capital Im Gp, Llc | 10 percent owner | 888 SEVENTH AVENUE, 30TH FLOOR, NEW YORK NY 10019 |
Miyoko Christina Yi | officer: Chief Operations Officer | C/O PROVENTION BIO, INC., 55 BROAD STREET, 2ND FLOOR, RED BANK NJ 07701 |
Benedict Osorio | officer: Chief Quality Officer | ONE WORLD TRADE CENTER, 47TH FLOOR, SUITE J, NEW YORK NY 10007 |
Eleanor Ramos | officer: Chief Medical Officer & COO | ZYMOGENETICS, INC., 1201 EASTLAKE AVENUE E, SEATTLE WA 98102 |
Thierry Chauche | officer: Chief Financial Officer | C/O PROVENTION BIO, INC., 55 BROAD STREET, 2ND FLOOR, RED BANK NJ 07701 |
From GuruFocus
By PRNewswire PRNewswire • 07-28-2022
By sperokesalga sperokesalga • 03-17-2023
By PRNewswire PRNewswire • 02-08-2023
By PRNewswire PRNewswire • 07-13-2022
By PRNewswire PRNewswire • 11-03-2022
By PRNewswire PRNewswire • 07-08-2022
By PRNewswire PRNewswire • 07-13-2022
By PRNewswire PRNewswire • 07-05-2022
By PRNewswire PRNewswire • 07-03-2022
By PRNewswire PRNewswire • 01-05-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.